Clinical Trial: Growth Differentiation Factor 15 in ICU Acquired Muscle Weakness

U.S., Dec. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06713746) titled 'Growth Differentiation Factor 15 in ICU Acquired Muscle Weakness' on Nov. 29, 2021.

Brief Summary: Intensive care unit -acquired weakness (ICU- AW) is a common consequence linked to a worse outcome as evidenced by prolonged mechanical ventilation, longer ICU stays, greater mortality rates and a lower quality of life for survivors, so early detection and treatment of ICU-AW are critical. However, there is no "gold standard" currently available for assessing and diagnosing ICU-AW. It's crucial to develop diagnostic methods that enable for early detection and risk stratification in all critically ill patients, such as:

GDF-15 (growth d...